TalkFDA
The Leader in Quality Life Science Training
2-DAY LIVE TECHNICAL SEMINAR

Nitrosamines After the Initial Assessment: When Does a Change Trigger Reassessment and How Should Impact Be Evaluated

Faculty
G. Sundar
Format
Live + Post-live Continued Access
Session Details
📅
Dates
September 10 - 11, 2026
🕙
Eastern Time (US/Canada)
11 AM to 1 PM
🕙
Time in GMT
3 PM to 5 PM
Modules
8 Technical Modules
Register Now

GROUP SAVINGS: Get your team to attend for just $490.

Individual registrations available too.

Course Overview & Structure

Make Clear Reassessment Trigger Decisions to Strengthen Testing and Control Strategy Justification.

Post-approval changes require disciplined technical evaluation over two focused days where reassessment triggers, scientific rationale, and testing decisions remain consistently supported.

This two-day seminar builds a structured approach for evaluating lifecycle changes, reassessment requirements, control strategies, and technical justification across evolving nitrosamine risk scenarios.

The seminar progresses from identifying reassessment triggers arising from lifecycle changes to evaluating their technical significance using current regulatory and scientific approaches. It then advances into analytical justification, NDSRI assessment, control strategy selection, and long-term monitoring practices that support consistent lifecycle management across changing products and manufacturing environments.

WHAT YOU'LL LEARN

Each of the 8 Modules will cover practical approaches in detail.

  • Determining When Nitrosamine Reassessment Should Be Initiated
  • Supplier Changes, Raw Material Changes, and Excipient Changes
  • Process Changes, Synthetic Route Modifications, Reagents, Catalysts, and Solvents
  • Formulation Changes, Manufacturing Transfers, and Other Product Lifecycle Changes
  • Evaluating Change Impact and Establishing Reassessment Requirements
  • Confirmatory Testing Versus Purge-Based Scientific Justification
  • NDSRI Assessment and Application of CPCA Principles
  • Testing Strategies, Control Strategies, Mitigation Measures, and Ongoing Monitoring Expectations
Who Should Attend

Designed for Organizations managing product lifecycle changes, nitrosamine risk assessments, regulatory submissions, and scientifically justified change control decisions.

Quality AssuranceQuality ControlManufacturingOperationsRegulatory AffairsAnalytical DevelopmentProcess ChemistryTechnical ServicesFormulation DevelopmentSupplier Quality
G. Sundar
Faculty

G. Sundar

G. Sundar brings more than 35 years of pharmaceutical quality, regulatory, analytical, and manufacturing experience spanning API, formulation, CRO, and quality systems. His extensive work implementing international regulatory expectations, conducting hundreds of GMP audits, and delivering advanced technical training equips him to guide detailed lifecycle decisions involving nitrosamine reassessment, change management, and regulatory justification.

After You Register

Everything related to your course lives in one place.

01

You receive confirmation and the course appears in your TalkFDA dashboard.

02

Your course page becomes the hub for joining the session and accessing materials.

03

At the scheduled time, click Join Session to enter the live Webex session.

04

After the session, playback becomes available on the same course page.

05

Complete the course and your certificate is unlocked in your learning history.

FDB3537
For Teams Seeking Deeper Implementation Support

Customized training is also available through TalkFDA Elite Training Labs.

This topic can also be delivered as a customized session for organizations seeking structured, implementation-focused training aligned with their internal processes and quality systems.

TalkFDA Elite Training Labs

Nitrosamines After the Initial Assessment:

When Does a Change Trigger Reassessment and How Should Impact Be Evaluated

📅 September 10 - 11, 2026 🕛 11 AM to 1 PM Eastern | 3 PM to 5 PM GMT